[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fUzI1oewa1_zWRqGfxLp5CO6emGooEE3Pvm-x6bwbGNM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":42,"rows":49},"Universitätsmedizin Mannheim",[4],78,false,4,9,28310,7,69,[14,16,18,20,23,25,27,29],{"name":15,"count":11},"Sepsis",{"name":17,"count":8},"Bronchial Asthma",{"name":19,"count":8},"Heart Failure",{"name":21,"count":22},"Pulmonary Healthy Controls",3,{"name":24,"count":22},"Coronary Artery Disease",{"name":26,"count":22},"Chronic Obstructive Pulmonary Disease",{"name":28,"count":22},"Interstitial Lung Disease",{"name":30,"count":22},"Cardiac Diseases",[32,37],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT02685605","Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme","2025-11","Temozolomide",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT04375605","Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ","2025-12","5-Fluorouracil",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,79,97,115,133,151,169,191,219,245,263,289,315,341,368,386],{"intervention":41,"totalTrials":51,"cells":52},1,{"EARLY_PHASE1":53,"PHASE1":56,"PHASE2":58,"PHASE3":60,"PHASE4":75,"NA":77},{"trials":54,"activeCount":55},[],0,{"trials":57,"activeCount":55},[],{"trials":59,"activeCount":55},[],{"trials":61,"activeCount":51,"soonestReadout":40},[62],{"nctId":38,"briefTitle":39,"status":63,"phases":64,"primaryCompletion":40,"completion":40,"start":65,"enrollment":66,"conditions":67,"interventions":69},"ACTIVE_NOT_RECRUITING",[46],"2020-06-03",342,[68],"Gastroesophageal Junction Adenocarcinoma",[41,70,71,72,73,74],"Calcium folinate","Oxaliplatin","Docetaxel","Oxaliplatin during radiotherapy","5-Fluorouracil during radiotherapy",{"trials":76,"activeCount":55},[],{"trials":78,"activeCount":55},[],{"intervention":70,"totalTrials":51,"cells":80},{"EARLY_PHASE1":81,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":93,"NA":95},{"trials":82,"activeCount":55},[],{"trials":84,"activeCount":55},[],{"trials":86,"activeCount":55},[],{"trials":88,"activeCount":51,"soonestReadout":40},[89],{"nctId":38,"briefTitle":39,"status":63,"phases":90,"primaryCompletion":40,"completion":40,"start":65,"enrollment":66,"conditions":91,"interventions":92},[46],[68],[41,70,71,72,73,74],{"trials":94,"activeCount":55},[],{"trials":96,"activeCount":55},[],{"intervention":71,"totalTrials":51,"cells":98},{"EARLY_PHASE1":99,"PHASE1":101,"PHASE2":103,"PHASE3":105,"PHASE4":111,"NA":113},{"trials":100,"activeCount":55},[],{"trials":102,"activeCount":55},[],{"trials":104,"activeCount":55},[],{"trials":106,"activeCount":51,"soonestReadout":40},[107],{"nctId":38,"briefTitle":39,"status":63,"phases":108,"primaryCompletion":40,"completion":40,"start":65,"enrollment":66,"conditions":109,"interventions":110},[46],[68],[41,70,71,72,73,74],{"trials":112,"activeCount":55},[],{"trials":114,"activeCount":55},[],{"intervention":72,"totalTrials":51,"cells":116},{"EARLY_PHASE1":117,"PHASE1":119,"PHASE2":121,"PHASE3":123,"PHASE4":129,"NA":131},{"trials":118,"activeCount":55},[],{"trials":120,"activeCount":55},[],{"trials":122,"activeCount":55},[],{"trials":124,"activeCount":51,"soonestReadout":40},[125],{"nctId":38,"briefTitle":39,"status":63,"phases":126,"primaryCompletion":40,"completion":40,"start":65,"enrollment":66,"conditions":127,"interventions":128},[46],[68],[41,70,71,72,73,74],{"trials":130,"activeCount":55},[],{"trials":132,"activeCount":55},[],{"intervention":73,"totalTrials":51,"cells":134},{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":141,"PHASE4":147,"NA":149},{"trials":136,"activeCount":55},[],{"trials":138,"activeCount":55},[],{"trials":140,"activeCount":55},[],{"trials":142,"activeCount":51,"soonestReadout":40},[143],{"nctId":38,"briefTitle":39,"status":63,"phases":144,"primaryCompletion":40,"completion":40,"start":65,"enrollment":66,"conditions":145,"interventions":146},[46],[68],[41,70,71,72,73,74],{"trials":148,"activeCount":55},[],{"trials":150,"activeCount":55},[],{"intervention":74,"totalTrials":51,"cells":152},{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":165,"NA":167},{"trials":154,"activeCount":55},[],{"trials":156,"activeCount":55},[],{"trials":158,"activeCount":55},[],{"trials":160,"activeCount":51,"soonestReadout":40},[161],{"nctId":38,"briefTitle":39,"status":63,"phases":162,"primaryCompletion":40,"completion":40,"start":65,"enrollment":66,"conditions":163,"interventions":164},[46],[68],[41,70,71,72,73,74],{"trials":166,"activeCount":55},[],{"trials":168,"activeCount":55},[],{"intervention":36,"totalTrials":51,"cells":170},{"EARLY_PHASE1":171,"PHASE1":173,"PHASE2":175,"PHASE3":177,"PHASE4":187,"NA":189},{"trials":172,"activeCount":55},[],{"trials":174,"activeCount":55},[],{"trials":176,"activeCount":55},[],{"trials":178,"activeCount":51,"soonestReadout":35},[179],{"nctId":33,"briefTitle":34,"status":63,"phases":180,"primaryCompletion":35,"completion":181,"start":182,"enrollment":183,"conditions":184,"interventions":186},[46],"2026-06","2016-12-09",314,[185],"Glioblastoma",[36],{"trials":188,"activeCount":55},[],{"trials":190,"activeCount":55},[],{"intervention":192,"totalTrials":51,"cells":193},"Dopamine infusion to brain dead organ donors",{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":202,"NA":217},{"trials":195,"activeCount":55},[],{"trials":197,"activeCount":55},[],{"trials":199,"activeCount":55},[],{"trials":201,"activeCount":55},[],{"trials":203,"activeCount":55},[204],{"nctId":205,"briefTitle":206,"status":207,"phases":208,"primaryCompletion":209,"completion":210,"start":211,"enrollment":212,"conditions":213,"interventions":216},"NCT00115115","Donor Dopamine and Initial Graft Function","COMPLETED",[47],"2007-12","2009-03","2004-03",487,[214,215],"Kidney Transplantation","ESRD",[192],{"trials":218,"activeCount":55},[],{"intervention":220,"totalTrials":51,"cells":221},"Capecitabine",{"EARLY_PHASE1":222,"PHASE1":224,"PHASE2":226,"PHASE3":228,"PHASE4":241,"NA":243},{"trials":223,"activeCount":55},[],{"trials":225,"activeCount":55},[],{"trials":227,"activeCount":55},[],{"trials":229,"activeCount":55},[230],{"nctId":231,"briefTitle":232,"status":207,"phases":233,"primaryCompletion":234,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":239},"NCT01500993","Capecitabine in the Perioperative Treatment of Rectal Cancer",[46],"2011-03","2002-03",401,[238],"Rectal Cancer",[220,240],"5-FU",{"trials":242,"activeCount":55},[],{"trials":244,"activeCount":55},[],{"intervention":240,"totalTrials":51,"cells":246},{"EARLY_PHASE1":247,"PHASE1":249,"PHASE2":251,"PHASE3":253,"PHASE4":259,"NA":261},{"trials":248,"activeCount":55},[],{"trials":250,"activeCount":55},[],{"trials":252,"activeCount":55},[],{"trials":254,"activeCount":55},[255],{"nctId":231,"briefTitle":232,"status":207,"phases":256,"primaryCompletion":234,"completion":234,"start":235,"enrollment":236,"conditions":257,"interventions":258},[46],[238],[220,240],{"trials":260,"activeCount":55},[],{"trials":262,"activeCount":55},[],{"intervention":264,"totalTrials":51,"cells":265},"Acetylsalicylic acid",{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":272,"PHASE4":285,"NA":287},{"trials":267,"activeCount":55},[],{"trials":269,"activeCount":55},[],{"trials":271,"activeCount":55},[],{"trials":273,"activeCount":55},[274],{"nctId":275,"briefTitle":276,"status":277,"phases":278,"primaryCompletion":279,"completion":279,"start":280,"enrollment":281,"conditions":282,"interventions":284},"NCT03063541","Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms","UNKNOWN",[46],"2022-10","2017-09-21",776,[283],"Unruptured Intracranial Aneurysms",[264],{"trials":286,"activeCount":55},[],{"trials":288,"activeCount":55},[],{"intervention":290,"totalTrials":51,"cells":291},"Dimethyl fumarate",{"EARLY_PHASE1":292,"PHASE1":294,"PHASE2":296,"PHASE3":309,"PHASE4":311,"NA":313},{"trials":293,"activeCount":55},[],{"trials":295,"activeCount":55},[],{"trials":297,"activeCount":55},[298],{"nctId":299,"briefTitle":300,"status":207,"phases":301,"primaryCompletion":302,"completion":303,"start":304,"enrollment":305,"conditions":306,"interventions":308},"NCT02546440","Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)",[45],"2021-09","2022-09","2015-09",25,[307],"Cutaneous T Cell Lymphoma",[290],{"trials":310,"activeCount":55},[],{"trials":312,"activeCount":55},[],{"trials":314,"activeCount":55},[],{"intervention":316,"totalTrials":51,"cells":317},"cilengitide",{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":339},{"trials":319,"activeCount":55},[],{"trials":321,"activeCount":55},[322],{"nctId":323,"briefTitle":324,"status":207,"phases":325,"primaryCompletion":326,"completion":326,"start":327,"enrollment":328,"conditions":329,"interventions":332},"NCT00884598","Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer",[44],"2012-10","2008-12",19,[330,331],"Brain and Central Nervous System Tumors","Lung Cancer",[316],{"trials":334,"activeCount":55},[],{"trials":336,"activeCount":55},[],{"trials":338,"activeCount":55},[],{"trials":340,"activeCount":55},[],{"intervention":342,"totalTrials":51,"cells":343},"mono bronchodilatation",{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":350,"PHASE4":352,"NA":354},{"trials":345,"activeCount":55},[],{"trials":347,"activeCount":55},[],{"trials":349,"activeCount":55},[],{"trials":351,"activeCount":55},[],{"trials":353,"activeCount":55},[],{"trials":355,"activeCount":55},[356],{"nctId":357,"briefTitle":358,"status":207,"phases":359,"primaryCompletion":360,"completion":361,"start":362,"enrollment":363,"conditions":364,"interventions":366},"NCT03287921","Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD",[],"2018-11-30","2019-04-11","2017-10-02",26,[365],"COPD",[342,367],"dual bronchodilatation",{"intervention":367,"totalTrials":51,"cells":369},{"EARLY_PHASE1":370,"PHASE1":372,"PHASE2":374,"PHASE3":376,"PHASE4":378,"NA":380},{"trials":371,"activeCount":55},[],{"trials":373,"activeCount":55},[],{"trials":375,"activeCount":55},[],{"trials":377,"activeCount":55},[],{"trials":379,"activeCount":55},[],{"trials":381,"activeCount":55},[382],{"nctId":357,"briefTitle":358,"status":207,"phases":383,"primaryCompletion":360,"completion":361,"start":362,"enrollment":363,"conditions":384,"interventions":385},[],[365],[342,367],{"intervention":387,"totalTrials":51,"cells":388},"Bronchodilator Agents",{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":397,"NA":399},{"trials":390,"activeCount":55},[],{"trials":392,"activeCount":55},[],{"trials":394,"activeCount":55},[],{"trials":396,"activeCount":55},[],{"trials":398,"activeCount":55},[],{"trials":400,"activeCount":55},[401],{"nctId":402,"briefTitle":403,"status":207,"phases":404,"primaryCompletion":405,"completion":405,"start":406,"enrollment":407,"conditions":408,"interventions":410},"NCT02826226","Effect of Bronchodilatator Testing on Multiple-breath-washout (MBW) Derived Lung Function Parameters",[],"2018-12","2016-05",145,[409],"Obstructive Ventilation Disorders",[387]]